Article

Assay to monitor bladder Cancer recurrence gets FDA nod

Downers Grove, IL-Vysis, Inc. has received FDA approval to market itsUroVysion assay for monitoring bladder cancer recurrence.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.